South and Central America Cancer Radiation Therapy Market Outlook (2021–2031)

The South and Central America cancer radiation therapy market size is expected to reach US$ 5,826.5 million by 2031 from US$ 2,874.0 million in 2024. The market is estimated to record a CAGR of 10.7% from 2025 to 2031.

Executive Summary and South and Central America Cancer Radiation Therapy Market Analysis:

The South and Central America cancer radiation therapy market is developing steadily as countries respond to rising cancer incidence, particularly for prostate, breast, and cervical cancers. Urban centers across the region are investing in modern radiotherapy infrastructure, including linear accelerators, image-guided radiotherapy (IGRT), and intensity-modulated radiotherapy (IMRT), while specialized cancer centers are expanding to meet growing patient demand. Collaboration with international technology providers, regional professional networks, and cross-border knowledge-sharing programs is enhancing clinical expertise and supporting standardized treatment protocols. Public-private partnerships and government-backed initiatives are promoting improved access to radiotherapy services, particularly in major metropolitan hubs.

Opportunities for market growth are emerging through the adoption of digital oncology solutions, telemedicine-enabled treatment planning, and AI-assisted dose optimization, which can extend advanced radiotherapy capabilities to underserved areas. Investments in workforce development, training programs, and integrated oncology workflows are enhancing operational efficiency and treatment quality across the region. As awareness of early diagnosis increases and healthcare systems continue to modernize, South and Central America are poised for sustained growth in cancer radiation therapy adoption, with an emphasis on improving precision, accessibility, and overall patient outcomes.

South and Central America Cancer Radiation Therapy Market - Strategic Insights:

South and Central America Cancer Radiation Therapy Market Segmentation Analysis:

Key segments that contributed to the derivation of the South and Central America cancer radiation therapy market analysis are type, cancer type, and end user.

• By type, the cancer radiation therapy market is segmented into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment dominated the market in 2024.
• Based on cancer type, the cancer radiation therapy market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, head & neck cancer, cervical cancer, and others. The lung cancer segment dominated the market in 2024.
• In terms of end user, the cancer radiation therapy market is segmented into hospitals, specialty clinics, ambulatory and radiotherapy centers, and academic and research institutes. The hospitals segment dominated the market in 2024.

South and Central America Cancer Radiation Therapy Market Drivers and Opportunities:

Increasing Occurrence of Cancer

Cancer incidence is rising across South and Central America due to population aging, urbanization, and lifestyle-related risk factors such as smoking, unhealthy diets, and reduced physical activity. Breast, prostate, colorectal, and cervical cancers are among the most prevalent in countries such as Brazil, Argentina, Mexico, and Colombia. Improved awareness and expanding screening programs have led to higher detection rates, increasing the number of patients requiring radiation therapy as part of comprehensive cancer care.

Healthcare infrastructure in the region varies widely, with urban centers equipped with modern oncology facilities while rural areas often face limited access. External beam radiation therapy is the predominant modality due to its versatility in treating multiple tumor types, while internal beam therapy is used for prostate, cervical, and gynecological cancers. This growing patient load is prompting hospitals to expand radiation oncology capacity and upgrade equipment.

Governments and private healthcare providers are investing in oncology infrastructure to manage the increasing cancer burden. Public - private partnerships and collaborations with international institutions are helping improve access to advanced treatment technologies. As cancer prevalence continues to rise, it remains a strong driver for sustained growth in the South and Central American cancer radiation therapy market.

The Increasing Appeal of Customized Healthcare

Personalized medicine is emerging as a key trend in South and Central America, driven by the need to improve treatment outcomes and reduce side effects. Radiation therapy is tailored to individual patients based on tumor characteristics, location, and patient-specific factors. This trend is fostering the adoption of advanced external beam techniques such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT).

Internal beam radiation therapy is also becoming more personalized, particularly for prostate, cervical, and gynecological cancers, where precise dose delivery significantly improves outcomes. Leading hospitals in Brazil, Argentina, and Mexico are integrating AI-assisted planning and advanced imaging tools to optimize therapy for individual patients.

Collaboration with international technology providers and training initiatives is enhancing the capability of regional cancer centers to deliver customized radiation therapy. Patients are becoming more informed and actively seek high-quality treatments that minimize side effects. This rising demand for personalized care creates substantial opportunities for equipment manufacturers, software developers, and healthcare systems across the South and Central American cancer radiation therapy market.

South and Central America Cancer Radiation Therapy Market Size and Share Analysis:

The South and Central America cancer radiation therapy market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report further examines subsegments categorized within type, cancer type, and end user, offering insights into their contribution to overall market performance.

By type, the external beam radiation therapy subsegment dominated the market in 2024. Due to its widespread availability, precision targeting, noninvasive nature, and effectiveness in treating diverse cancers, it is the preferred choice across global oncology practices.

Based on cancer type, the lung cancer subsegment dominated the market in 2024. Due to its high incidence, strong link with smoking and pollution, late‑stage diagnoses, and reliance on advanced radiation techniques, it is the most treated cancer type globally.

In terms of end user, the hospitals subsegment dominated the market in 2024. Hospitals dominated the market since they provide comprehensive cancer care, advanced radiation infrastructure, skilled oncologists, and integrated treatment pathways, making them the primary setting for delivering radiation therapy services.

South and Central America Cancer Radiation Therapy Market Report Highlights:

South and Central America Cancer Radiation Therapy Market Report Coverage and Deliverables:

The "South and Central America Cancer Radiation Therapy Market Size and Forecast (2021 - 2031)" report provides a detailed analysis of the market covering below areas:

• South and Central America Cancer Radiation Therapy market size and forecast at regional and country levels for market segments covered under the scope
• South and Central America Cancer Radiation Therapy market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• South and Central America Cancer Radiation Therapy market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Cancer Radiation Therapy market
• Detailed company profiles, including SWOT analysis

South and Central America Cancer Radiation Therapy Market Geographic Insights:

The geographical scope of the South and Central America Cancer Radiation Therapy market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2024.

Brazil dominates the South and Central America cancer radiation therapy market due to its extensive oncology infrastructure, concentration of advanced treatment centers, and well-trained clinical workforce. Major cities such as São Paulo, Rio de Janeiro, and Brasília host a majority of high-technology radiotherapy facilities, including linear accelerators, IMRT, IGRT, stereotactic radiotherapy, and brachytherapy units. Hospitals and cancer centers in Brazil integrate radiotherapy with multidisciplinary care, ensuring comprehensive treatment approaches for complex cases.

The country's leadership is reinforced by continuous investment in equipment modernization, research initiatives, and digital oncology platforms, which enhance treatment planning, patient management, and workflow efficiency. Brazil also benefits from structured training programs for radiation oncologists, physicists, and technologists, ensuring expertise in advanced radiotherapy modalities. Its position as a regional oncology hub attracts patients from neighboring countries seeking high-quality care. Combined infrastructure, clinical expertise, and strategic investment initiatives consolidate Brazil's dominance in South and Central America's cancer radiation therapy market.

South and Central America Cancer Radiation Therapy Market Research Report Guidance:

• The report includes qualitative and quantitative data in the South and Central America cancer radiation therapy market across type, cancer type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Cancer Radiation Therapy market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Cancer Radiation Therapy market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Cancer Radiation Therapy market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover South and Central America Cancer Radiation Therapy market segments by type, cancer type, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Cancer Radiation Therapy market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

South and Central America Cancer Radiation Therapy Market News and Key Development:

The South and Central America Cancer Radiation Therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America cancer radiation therapy market are:

• In May 2024, Elekta announced the launch of its latest linear accelerator system, Evo, featuring AI‑enhanced imaging and online/offline adaptive radiotherapy capabilities, aimed at improving the precision and flexibility of radiation therapy delivery, a development highlighted as relevant to expanding advanced radiotherapy technology adoption across markets, including South & Central America.
• In May 2024, GE HealthCare announced the launch of Revolution RT radiation therapy CT solution, designed to increase imaging accuracy and improve simulation workflows for oncologists, a product initiative noted for its applicability to radiotherapy treatment pathways in South & Central America.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Union for International Cancer Control (UICC)
• International Agency for Research on Cancer (IARC)
• American Society for Radiation Oncology (ASTRO)
• European Society for Radiotherapy & Oncology (ESTRO)
• Asia-Oceania Federation of Organizations for Radiological Technology (AOFRT)
• Company Websites
• Company Annual Reports
• Company Investor Presentations